CLINICAL TRIALS PROFILE FOR LAMIVUDINE; RALTEGRAVIR POTASSIUM
✉ Email this page to a colleague
All Clinical Trials for lamivudine; raltegravir potassium
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01105611 ↗ | Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users | Unknown status | St. James's Hospital, Ireland | Phase 4 | 2010-08-01 | The purpose of this study is to compare how safe, tolerable, and effective a novel drug, raltegravir, is to a commonly used combination, atazanavir/ritonavir, as initial treatment in HIV/Hepatitis C co-infected injecting drug users on a methadone program. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for lamivudine; raltegravir potassium
Condition Name
Clinical Trial Locations for lamivudine; raltegravir potassium
Clinical Trial Progress for lamivudine; raltegravir potassium
Clinical Trial Phase
Clinical Trial Sponsors for lamivudine; raltegravir potassium
Sponsor Name